Earnings Feed
Start Free
Home/Filings/4/0001214659-20-007419
4//SEC Filing

Greenberg Richard S 4

Accession 0001214659-20-007419

CIK 0001625288other
View on SEC.govCompany Profile

Filed

Aug 20, 8:00 PM ET

Accepted

Aug 21, 1:17 PM ET

Size

8.7 KB

Accession

0001214659-20-007419

Insider Transaction Report

Form 4
Period: 2020-08-19
NEXIEN BIOPHARMA, INC.NXEN
Greenberg Richard S
DirectorEVP and Chairman10% Owner
Transactions
  • Award

    Stock option - right to buy

    2020-08-19+2,500,000→ 2,500,000 total
    Exercise: $0.08From: 2020-08-19Exp: 2027-08-19→ Common Stock (2,500,000 underlying)
Holdings

  • Stock option - right to buy

    Exercise: $0.54From: 2018-07-25Exp: 2025-07-25→ Common Stock (420,000 underlying)
    420,000

  • Common Stock

    2,688,880

  • Stock option - right to buy

    Exercise: $0.66From: 2018-10-26Exp: 2025-10-26→ Common Stock (100,000 underlying)
    100,000
Footnotes (2)
  • [F1]Options to purchase 1,666,667 shares are vested and immediately exercisable. Options to purchase 833,333 shares vest over 4 quarters beginning September 30, 2020.
  • [F2]Granted in lieu of cash compensation.

Documents

1 file

Issuer

NEXIEN BIOPHARMA, INC.

CIK 0001625288

→
Entity typeother

Related Parties

1
  • filerCIK 0001719461

Filing Metadata

Form type
4
Filed
Aug 20, 8:00 PM ET
Accepted
Aug 21, 1:17 PM ET
Size
8.7 KB
View on SEC.gov